KORU Medical Systems Announces Development Agreement for Innovation in Subcutaneous Immunoglobulin Infusion Systems Life Science Investing
NeuroPace Reports Third Quarter 2025 Financial Results and Increases 2025 Revenue Guidance Medical Device Investing
Broadwood Partners Condemns Alcon's Fallacious Attacks on STAAR Surgical and Its Prospects Life Science Investing
CMS Establishes Coding Validating Sensus SRT for Treating Non-Melanoma Skin Cancer Life Science Investing
Data Presented at the 2025 Southern Region Burn Conference Reinforce RECELL® System as a Standard of Care in Acute Wound Treatment Medical Device Investing
Yunqi Capital Issues Letter to STAAR Surgical Board Calling for Termination of the Proposed Merger with Alcon Life Science Investing
